G.Barekat Pharm (XTEH:BRKT1) Buyback Yield % : 0.00 (As of May. 16, 2024)

View and export this data going back to 2017. Start your Free Trial

What is G.Barekat Pharm Buyback Yield %?

Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.

G.Barekat Pharm's current buyback yield was 0.00%.

G.Barekat Pharm Buyback Yield % Historical Data

The historical data trend for G.Barekat Pharm's Buyback Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

G.Barekat Pharm Buyback Yield % Chart

G.Barekat Pharm Annual Data

Trend

Mar16

Mar17

Buyback Yield %

G.Barekat Pharm Semi-Annual Data
	Mar16	Mar17
Buyback Yield %	-	-

Competitive Comparison of G.Barekat Pharm's Buyback Yield %

For the Biotechnology subindustry, G.Barekat Pharm's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

G.Barekat Pharm's Buyback Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, G.Barekat Pharm's Buyback Yield % distribution charts can be found below:

* The bar in red indicates where G.Barekat Pharm's Buyback Yield % falls into.

G.Barekat Pharm Buyback Yield % Calculation

Buyback yield is a measure of shareholder return.

G.Barekat Pharm's Buyback Yield for the fiscal year that ended in Mar. 2017 is calculated as

Buyback Yield	=	Net Issuance of Stock			/	Market Cap
	=	- (Repurchase of Stock	+	Issuance of Stock)	/	Market Cap
	=	- (0	+	0)	/	6602817.0726
	=	0.00%

G.Barekat Pharm's annualized Buyback Yield for the quarter that ended in Mar. 2017 is calculated as

Buyback Yield	=	Net Issuance of Stock		(Annualized)			/	Market Cap
	=	- (Repurchase of Stock	+	Issuance of Stock)	*	Annualized Factor	/	Market Cap
	=	- (0	+	0)	*	1	/	6602817.0726
	=	0.00%

In calculating the annualized data, the Repurchase of Stock and Issuance of Stock data used here is one times the annual (Mar. 2017) data.

G.Barekat Pharm Buyback Yield % Related Terms

Thank you for viewing the detailed overview of G.Barekat Pharm's Buyback Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

G.Barekat Pharm (XTEH:BRKT1) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » G.Barekat Pharm (XTEH:BRKT1) » Definitions » Buyback Yield %

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 11, 5th Alley, Bucharest Avenue, Argentina Square, Tehran, IRN

Website

http://www.bpharmed.com

G.Barekat Pharm focuses on the introduction of new pharmaceutical fields such as biotechnology, drug delivery which includes nanotechnology, slow release drugs, and new technologies for health, development of cellular molecular industries like tuberculosis, gene therapy, immunotherapy, and tissue technology.

G.Barekat Pharm (XTEH:BRKT1) Headlines

No Headlines